Table: begin end state 1 23 cytoplasmic 24 52 transmembrane 53 62 non-cytoplasmic 63 80 transmembrane 81 100 cytoplasmic 101 123 transmembrane 124 142 non-cytoplasmic 143 161 transmembrane 162 167 cytoplasmic 168 192 transmembrane 193 199 non-cytoplasmic 200 231 transmembrane 232 251 cytoplasmic 252 273 transmembrane 274 290 non-cytoplasmic 291 316 transmembrane 317 333 cytoplasmic 334 357 transmembrane 358 362 non-cytoplasmic 363 385 transmembrane 386 404 cytoplasmic 405 426 transmembrane 427 432 non-cytoplasmic 433 453 transmembrane 454 464 cytoplasmic 465 489 transmembrane 490 509 non-cytoplasmic 510 541 transmembrane 542 552 cytoplasmic 553 575 transmembrane 576 592 non-cytoplasmic 593 615 transmembrane 616 618 cytoplasmic
Input: >HSERO_RS05555 FitnessBrowser__HerbieS:HSERO_RS05555 MSALSLEQPVADERSLAARLEHWLGLAIEIPAAALVVGEVAVLLAGVIMRFIFNNPIPWA DELASILFLWLANLGAAVALRRGTHMRTTVLVGFMSERGKAWAEALAIIAPCVMLLILMH PMWEYAEDEMFVQTPALGWPNTVRAAAVAVGAALMIALSLLRISRQKLVDLVGVLALLAV VAGAMYLGAAWLQAIGNWNLVVFFGLVLAVSVLLGIPIAFCFGLATVAFMLTVTTSPLAV VAGRFDEGMSSLILLAVPLFILLGHLVEMTGMAKAMVDFLASLLGHVRGGLNYVLLGAML LVSGISGAKTADMAAVAPVLLPEMKRRGNHEGELISLLAASGAMAETIPPSLVLITIGSV AGVSIAALFTGGIMPGIVLAVLLAILARWRSAEIMEGIQRAPGRVVLRTLIIALPALLLP ILIRTAVVEGVATATEVSTIGIAYSVVAGLLVYRKFDWKRLYPMLVDTAALSGAILFIIG TATGMSWALTQSGFSHALAEAMTSVPGGKYGFLLVSIAAFIVLGSVLEGIPAMVLFAPLL FPVAKAIGVHEVHYAMVIILSMGVGLFAPPFGLGYYAACTIGRVHPDVAVKRIWPYLGAL VVGLLIVAFVPWFSIGFL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server